cadenas

ITCC-068 VENETOCLAX

  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-068 VENETOCLAX

A Phase 1 Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric Patients with Select Relapsed or Refractory Malignancies

Promotor Name : ABBVIE

Investigator Name : J. VORMOOR

Trial registered on clinicaltrial.gov: NCT03236857